Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marta Zafra-Poves"'
Autor:
Verónica Castillo-Guardiola, Laura Rosado-Jiménez, María Desamparados Sarabia-Meseguer, Miguel Marín-Vera, José Antonio Macías-Cerrolaza, Rosario García-Hernández, Marta Zafra-Poves, Pilar Sánchez-Henarejos, María Ángeles Moreno-Locubiche, Encarnación Cuevas-Tortosa, María Arnaldos-Carrillo, Francisco Ayala de la Peña, José Luis Alonso-Romero, José Antonio Noguera-Velasco, Francisco Ruiz-Espejo
Publikováno v:
European journal of medical genetics. 65(4)
BRCA1 and BRCA2 are the two main genes causing hereditary breast and ovarian cancer (HBOC). However, thanks to the development of Next Generation Sequencing (NGS), other genes linked to this syndrome (CHEK2, BRIP1, ATM and PALB2 among others) can be
Autor:
Vanessa Roldán Schilling, Elena Garcia Martinez, Elisa García Garre, Silvia Garcia, Esther Navarro Manzano, Enrique Gonzalez Billalabeitia, Marta Zafra Poves, Gregory Y.H. Lip, Alejandra Ivars Rubio, Ginés Luengo Gil, Francisco Ayala de la Peña
Publikováno v:
Breast cancer research and treatment. 169(1)
Therapeutic exploitation of angiogenesis in breast cancer has been limited by the lack of reliable biomarkers. Circulating small-sized endothelial microparticles (sEMP) are likely to play a significant role as messengers of angiogenesis. Higher level
Autor:
Ana Isabel Sánchez Bermúdez, Xavier Gabaldó Barrios, Mª Rosario García Hernández, Enrique Martínez Barba, Francisco Ruiz Espejo, Mª de los Desamparados Sarabia Meseguer, José Antonio Noguera Velasco, Francisco Ayala de la Peña, Miguel Marín Vera, José Antonio Macías Cerrolaza, José Luis Alonso Romero, Ángeles Aliaga Baño, Marta Zafra Poves, Isabel Tovar Zapata, Pilar Sánchez Henarejos, Pedro Luis Martínez Hernández, Verónica Castillo Guardiola, Encarna Cuevas Tortosa
Publikováno v:
Familial cancer. 16(4)
This is the first study performed in Murcia (south-eastern Spain) in which 592 families with hereditary breast and ovarian cancer were identified thanks to Genetic Counselling Units from this area over 6 years. Diagnostic performance was 18.1% and 19
Autor:
Maria Angeles Vicente Conesa, Vicente Vicente, Francisco Ayala de la Peña, Elisa Garcia-Garre, Edgar Urrego, Enrique Gonzalez-Billalabeitia, Elena García-Martínez, Marta Zafra Poves, Pilar de la Morena Barrio
Publikováno v:
ResearcherID
Purpose Although diabetes mellitus (DM) is recognized as a risk factor for chemotherapy-induced neurotoxicity, its true impact on intensity and time course of peripheral neuropathy is still unclear. The goal was to analyze the relevance of preexistin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d15117d822331ca7d392bcfaf92d7f8c
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000352962200007&KeyUID=WOS:000352962200007
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000352962200007&KeyUID=WOS:000352962200007